SCHEMBL9168636

SCHEMBL9168636

CCOC(=O)C(C(=O)OCC)C1CCCC(O)C1c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.47
L3MBTL1 Q9Y468 1/20 0.44
TP53 P04637 1/20 0.43
SLC6A2 P23975 3/20 0.41
SLC6A3 Q01959 3/20 0.41
SLC6A4 P31645 2/20 0.41
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C19 P33261 1/20 0.40
KDM4E B2RXH2 1/20 0.40
PIN1 Q13526 1/20 0.39
BRD4 O60885 1/20 0.39
MAPT P10636 1/20 0.39
PKM P14618 1/20 0.39
NPC1 O15118 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9169697 0.81 SLC18A3 (0.41)
SCHEMBL28441912 0.80 MAPT (0.51) TSHRL3MBTL1TP53MEN1KMT2A
SCHEMBL9171989 0.76 TSHR (0.45) TSHRL3MBTL1TP53SLC6A2SLC6A3
SCHEMBL28929570 0.71 CYP1A2 (0.54) TP53CYP1A2CYP2C19MAPTNPC1
SCHEMBL22002721 0.71 TSHR (0.41) TSHRTP53MEN1KMT2ACYP1A2
SCHEMBL16050429 0.70 TSHR (0.60) TSHRL3MBTL1SLC6A2SLC6A3SLC6A4
SCHEMBL21558169 0.70 SLC18A3 (0.44) TSHRCYP1A2CYP2D6
SCHEMBL28278395 0.69 MAPT (0.41) TSHRL3MBTL1SLC6A2SLC6A3SLC6A4
SCHEMBL27671845 0.69 L3MBTL1 (0.49) TSHRL3MBTL1SLC6A2SLC6A3SLC6A4
SCHEMBL9166296 0.69 POLB (0.40) L3MBTL1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5387595-A Antiinflammatory agents MERCK & CO., INC. (US) 1995-02-07 US disclosed
WO-1994004487-A1 ALICYCLIC COMPOUNDS AS TACHYKININ RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 1994-03-03 WO disclosed